Skip to content
zameds

Isoniazid, thiacetazone

Sold as Iscotin, Thiazina tabs, Isoniazid with thiacetazone

Every registration of this product has been cancelled.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
3
Registrations
3

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Rm salters *CancelledIscotinNot statedA0281Not determinedNone
Westdene Products (Pty) Ltd *CancelledThiazina tabsNot statedA0700Not determinedNone
Pharmacare limited û woodmeadCancelledIsoniazid with thiacetazoneNot statedJ0161Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Iscotin

TABLET ISONIAZID A 300 MG THIACETAZONE A 40 MG

Not listedA0281CancelledNot determinedNone
Thiazina tabs

TABLET ISONIAZID A 50 MG THIACETAZONE A 25 MG

Not listedA0700CancelledNot determinedNone
Isoniazid with thiacetazone

EACH TABLET CONTAINS ISONIAZID 133 MG THIACETAZONE 50 MG

Not listedJ0161J/20.2.3/161CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Isoniazid

    Consolidated Schedules 06 July 2026, line 6819

  • S3: Thiacetazone

    Consolidated Schedules 06 July 2026, line 4308

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles